Benitec Biopharma Inc.
Benitec Biopharma Inc. (BNTC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BNTC · as of Jun 8, 2026
Key Statistics
Explore Benitec Biopharma Inc. Data
bntc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The BNTC analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $25.00, representing +136.97% upside from the current price of $10.55.
Competitors & Peers
bntc competitorsBNTC
AUTL
GALT
IMAB
LCTX
NGNEStock Performance
Full HistoryAbout Benitec Biopharma Inc.
Benitec Biopharma Inc. a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chro…
what is benitec biopharma inc. · bntc stock overview · benitec biopharma inc. company profile · who is benitec biopharma inc. ceo · bntc NASDAQ · benitec biopharma inc. headquarters · benitec biopharma inc. business segments
About Stock Overview & Key Data
Benitec Biopharma Inc. (BNTC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 24, 2014. As of the latest trading session, BNTC stock price is $10.55, with a market capitalization of $276.9M. The stock has returned -34.76% over the past 12 months and -21.68% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Benitec Biopharma Inc. stock is Buy, with an average 12-month price target of $25.00. In fiscal year 2025, Benitec Biopharma Inc. reported revenue of — and net income of -$37.9M. For detailed data — including Benitec Biopharma Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Benitec Biopharma Inc. (BNTC) stock price is $10.55. The stock is traded on NASDAQ under the ticker symbol BNTC. The 52-week range is $9.85 – $17.15.